Free Trial Information
BioCentury | Aug 28, 2020
Finance

Turning to solid tumors, cell therapy play Triumvira earns syndicate’s $55M vote of confidence

...CARs”).By late 2019, the company was preparing to start a Phase I/II trial of a TAC01-CD19...
Read More
Items per page:
1 - 1 of 1